Journal
METABOLIC ENGINEERING COMMUNICATIONS
Volume 13, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.mec.2021.e00181
Keywords
Biotechnology; Cell line engineering; Chinese hamster ovary; Hypoxia; Perfusion; Recombinant protein expression
Categories
Funding
- German Federal Ministry of Education and Research, funding program Forschung an Fachhochschulen [13FH162PA6]
Ask authors/readers for more resources
Creating novel engineered CHO cell lines under hypoxic conditions significantly improved protein expression output in batch fermentations and high cell density perfusion processes, demonstrating the potential of utilizing adverse oxygen limitations to optimize biotherapeutic production.
Oxygen deficiency (hypoxia) induces adverse effects during biotherapeutic protein production leading to reduced productivity and cell growth. Hypoxic conditions occur during classical batch fermentations using high cell densities or perfusion processes. Here we present an effort to create novel engineered Chinese hamster ovary (CHO) cell lines by exploiting encountered hypoxic bioprocess conditions to reinforce cellular production capacities. After verifying the conservation of the hypoxia-responsive pathway in CHO cell lines by analyzing oxygen sensing proteins HIF1a, HIF1 beta and VDL, hypoxia-response-elements (HREs) were functionally analyzed and used to create hypoxia-responsive expression vectors. Subsequently engineered hypoxia sensitive CHO cell lines significantly induced protein expression (SEAP) during adverse oxygen limitation encountered during batch fermentations as well as high cell density perfusion processes (2.7 fold). We also exploited this novel cell system to establish a highly effective oxygen shift as innovative bioprocessing strategy using hypoxia induction to improve production titers. Thus, substantial improvements can be made to optimize CHO cell productivity for novel bioprocessing challenges as oxygen limitation, providing an avenue to establish better cell systems by exploiting adverse process conditions for optimized biotherapeutic production.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available